[1] Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of infection and public health. 2020 Dec 1;13(12):1791-6. [10.1016/j.jiph.2020.10.008 ] [PMID]
[2] Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of infection and public health. 2020 Dec 1;13(12):1791-6. [10.1016/j.jiph.2020.10.008 ] [PMID]
[3] Laukka D, Parkkola R, Hirvonen J, Ylikotila P, Vahlberg T, Salo E, Kivelev J, Rinne J, Rahi M. Brain white matter hyperintensities in Kawasaki disease: A case–control study. Frontiers in Neuroscience. 2022 Oct 18;16:995480. [10.3389/fnins.2022. 995480 ] [PMID]
[4] Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nature Reviews Rheumatology. 2020 Jul;16(7):391-405. [10.1038/s41584-020-0426-0 ] [PMID]
[5] Soni PR, Noval Rivas M, Arditi M. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Current Rheumatology Reports. 2020;22(2):6. [10.1007/s11926-020-0882-1 ] [PMID]
[6] Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Archives of pediatrics & adolescent medicine. 2006 Jul 1;160(7):686-90. [10.1001/archpedi.160.7.686 ] [PMID]
[7] Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Archives of pediatrics & adolescent medicine. 2006 Jul 1;160(7):686-90. [10.1001/archpedi.160.7.686 ] [PMID]
[8] Eun LY, Kim JH, Jung JW, Choi JY. Myocardial layers specific strain analysis for the acute phase of infant Kawasaki disease. Pediatric cardiology. 2016 Dec;37:1404-8. [10.1007/s00246-016-1448-x ] [PMID]
[9] Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem inflammatory syndrome in children (MIS-C) with COVID-19: insights from simultaneous familial Kawasaki disease cases. International Journal of Infectious Diseases. 2020 Aug 1;97:371-3. [10.1016/j.ijid.2020.06.014 ] [PMID]
[10] Iio K, Matsubara K, Miyakoshi C, Ota K, Yamaoka R, Eguchi J, Matsumura O, Okutani T, Ueda I, Nishiyama M. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ paediatrics open. 2021;5(1). [10.1136/bmjpo-2021-001034 ] [PMID]
[11] Alizargar J. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. Journal of the Formosan Medical Association. 2020 Nov;119(11):1713. [10.1016/j.jfma.2020.05. 030] [PMID]
[12] Rathore SS, Rojas GA, Sondhi M, Pothuru S, Pydi R, Kancherla N, Singh R, Ahmed NK, Shah J, Tousif S, Baloch UT. Myocarditis associated with Covid‐19 disease: a systematic review of published case reports and case series. International journal of clinical practice. 2021 Nov;75(11):e14470. [10.1111/ijcp.14470] [PMID]
[13] Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M,
Salerno C, Hernandez-Montfort J, Islam AM. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovascular Revascularization Medicine. 2021 Feb 1;23:107-13. [10.1016/j.carrev.2020.08.028 ] [PMID]
[14] Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, Hernandez-Montfort J, Islam AM. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovascular Revascularization Medicine. 2021 Feb 1;23:107-13. [10.1016/j.carrev.2020.08.028 ] [PMID]
[15] Beşler MS, Arslan H. Acute myocarditis associated with COVID-19 infection. The American journal of emergency medicine. 2020;38(11):2489.e1-.e2. [10.1016/j.carrev.2020.08.028] [PMID]
[16] Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet (London, England). 2020;395(10239):1771-8. [10.1016/S0140-6736(20)31103-X] [PMID]
[17] Esmaeilzadeh H, Mortazavi N, Salehi A, Fatemian H, Dehghani SM, Vali M, Vardanjani HM. Effect of COVID-19 on Kawasaki disease: decrease age of onset and increase skin manifestation. BMC pediatrics. 2021 Dec;21:1-6. [10.1186/s12887-021-03060-w] [PMID]
[18] Shahbaznejad L, Navaeifar MR, Abbaskhanian A, Hosseinzadeh F, Rahimzadeh G, Rezai MS. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran. BMC pediatrics. 2020 Dec;20:1-2. [10.1186/s12887-020-02415-z ] [PMID]
[19] Nihal NG, Challuri P, Reddy MPK, Babu RS. Stress and anxiety among medical interns and doctors deputed in COVID duties: A cross-sectional study. Telangana Journal of Psychiatry. 2021;7(2):122. [Link]
[20] Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M, Léger PL, Galeotti C, Claude C, Wiedemann A, Lachaume N. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. Jama. 2021 Mar 2;325(9):855-64. [10.1001/jama.2021.0694 ] [PMID]
[21] Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Jama. 2020 Jul 21;324(3):259-69. [10.1001/jama.2020. 10369] [PMID]
[22] Ziaee V, Assari R, Mamishi S, Zeinaloo A, Mohammadpour M, Malekzadeh I, COVID MC. An algorithmic approach to multisystem inflammatory syndrome in children with COVID-19: tehran children’s medical center protocol. Iranian Journal of Pediatrics. 2020 Oct 31;30(5). [Link]
[23] Beşler MS, Arslan H. Acute myocarditis associated with COVID-19 infection. The American Journal of Emergency Medicine. 2020;38(11):2489.e1-.e2. [10.1016/j.carrev.2020.08.028] [PMID]
[24] Kariyanna PT, Sutarjono B, Grewal E, Singh KP, Aurora L, Smith L, Chandrakumar HP, Jayarangaiah A, Goldman SA, Salifu MO, McFarlane IM. A systematic review of COVID-19 and myocarditis. American journal of medical case reports. 2020;8(9):299. [Link]
[25] Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY,
Jundishapur
Scientific Medical Journal
January & February 2024. Vol 22. No 6
Tajdini P, et al. Frequency of Myocarditis and Kawasaki Disease. JSMJ. 2024; 22(6):757-767
767
Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26;110(17):2747-71 [10.1161/01.CIR.0000145143.19711.78 ] [PMID]
[26] Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology?. International journal of infectious diseases. 2005 Jul 1;9(4):185-94. [PMID]
[27] Mardi P, Esmaeili M, Iravani P, Abdar ME, Pourrostami K, Qorbani M. Characteristics of children with Kawasaki disease-like signs in COVID-19 pandemic: a systematic review. Frontiers in pediatrics. 2021 Mar 18;9:625377.. [10.3389/fped.2021.625377 ] [PMID]
)